|
|
CAPREOMYCIN CO-ADMINISTRATION WITH THE DRUG MAY CAUSE INCREASED RISK OF RESPIRATORY PARALYSIS & RENAL DYSFUNCTION
|
COLISTIN HAS SOME NEUROMUSCULAR BLOCKING ACTION & ANATGONISE NEOSTIGMINE ACTION
|
COLISTIN HAS SOME NEUROMUSCULAR BLOCKING ACTION & ANATGONISE NEOSTIGMINE ACTION
|
COLISTIN HAS SOME NEUROMUSCULAR BLOCKING ACTION & ANATGONISE NEOSTIGMINE ACTION
|
COLISTIN HAS SOME NEUROMUSCULAR BLOCKING ACTION & ANATGONISE NEOSTIGMINE ACTION
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|